FilingReader Intelligence
BioDlink profit plunges 87% on project delays
August 12, 2025 at 05:01 PM UTC•By FilingReader AI
BioDlink International's net profit plummeted 87% to 4.1 million yuan for the first half of 2025, while revenue fell 6% to 489.1 million yuan.
The decline was attributed to key projects missing delivery milestones and increased depreciation from major construction projects. However, operating cash flow rose 25% to 34.8 million yuan.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1875•Hong Kong Exchange
News Alerts
Get instant email alerts when TOT BIOPHARM International publishes news
Free account required • Unsubscribe anytime